Treatment of Pediatric Acute Graft-versus-Host Disease—Lessons from Primary Immunodeficiency?

Allogeneic hematopoietic stem cell transplant (HSCT) is used to treat increasing numbers of malignant and non-malignant disorders. Despite significant advances in improved human leukocyte antigens-typing techniques, less toxic conditioning regimens and better supportive care, resulting in improved c...

Descripción completa

Detalles Bibliográficos
Autores principales: Flinn, Aisling M., Gennery, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359217/
https://www.ncbi.nlm.nih.gov/pubmed/28377772
http://dx.doi.org/10.3389/fimmu.2017.00328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359217/
https://www.ncbi.nlm.nih.gov/pubmed/28377772
http://dx.doi.org/10.3389/fimmu.2017.00328

Ejemplares similares